secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009912
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q4 2025 revenue up 15-17% YoY to ~$14.7M; positive cash flow in quarter
------------------------------------------------------------------------------

- Q4 2025 revenue expected $14.6-14.8M vs $12.7M prior year, +15-17% YoY.
- Full-year 2025 revenue expected $52.5-52.7M vs $48.7M in 2024, +8% YoY.
- Achieved positive cash flow in Q4 and expects positive adjusted EBITDA for full-year 2025.
- Sold 15,800 Cyclo G6 probes in Q4 (up 19% YoY); 44 systems sold vs 47 prior year.
- CEO cites cost reductions, gross margin expansion, and improved commercial efficiency as drivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526009912/0001193125-26-009912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526009912/irix-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer